ACT-Accelerator Ethics & Governance Working Group
Background and mission
The Access to COVID-19 Tools (ACT) Accelerator is a global collaboration to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines. It brings together governments, scientists, businesses, civil society, and philanthropists and global health organizations.
WHO has established an international Working Group to develop a high-level ethical framework for WHO and its partners in the ACT Accelerator. The Group responds to ethical and governance issues as they arise in the ACT Accelerator, and promotes the effective and consistent incorporation of ethics into the various ACT Accelerator initiatives.
The Group has been involved in the following activities and outputs cover the following:
- Allocation of diagnostics
- Allocation of therapeutics
- Review of data governance framework
- Development of policy brief on placebo use in vaccine trials
Über uns
Publications
This framework has been developed in order to assist stakeholders in navigating ethical issues and dilemmas, and more broadly make value-informed decisions,...
Related groups